hgh igf 1 lr3 Human LR3-IGF-1 Recombinant Protein Tag Free Lyophilized – Innovative Research igf 1 lr3 and hgh

Long-term monitoring with hormone panels and regular follow-ups ensures correct dosing and tracks effectiveness over time

Side-by-Side Comparison FDA Approved Tesamorelin Yes (Egrifta, 2010) CJC-1295/Ipamorelin No (compounded) Tesamorelin/Ipamorelin No (compounded combo) Mechanism Tesamorelin GHRH receptor (single pathway) CJC-1295/Ipamorelin GHRH + ghrelin receptor (dual pathway) Tesamorelin/Ipamorelin GHRH + ghrelin (FDA molecule + dual pathway) Half-Life Extension Tesamorelin DPP-IV protection (~26 min) CJC-1295/Ipamorelin Enzyme-resistant substitutions (~30 min, no-DAC) Tesamorelin/Ipamorelin DPP-IV protection + ghrelin receptor Clinical Evidence Tesamorelin 2 Phase 3 RCTs, 816 patients CJC-1295/Ipamorelin Phase 2 (CJC-1295) Tesamorelin/Ipamorelin Individual components well-studied Fat Loss Data Tesamorelin 15% visceral fat reduction (CT-measured) CJC-1295/Ipamorelin Body composition improvement (practitioner data) Tesamorelin/Ipamorelin Combined mechanisms Liver Fat Tesamorelin 35% normalized liver fat (Lancet HIV, 2019) CJC-1295/Ipamorelin Not specifically studied Tesamorelin/Ipamorelin Tesamorelin component covers this Sleep Benefit Tesamorelin Moderate CJC-1295/Ipamorelin Strong (dual-pathway overnight GH) Tesamorelin/Ipamorelin Strong Regulatory Pedigree Tesamorelin Strongest (current FDA approval) CJC-1295/Ipamorelin Standard compounded Tesamorelin/Ipamorelin FDA molecule + compounded Tesamorelin: The FDA-Approved Option Tesamorelin has the strongest clinical evidence of any growth hormone peptide

Too much too soon can lead to side effects like fatigue, blood sugar crashes, or unwanted water retention

Neurogen Research offers this premium 20mg blend with over 99% purity